Aridis Pharmaceuticals, Inc.
ARDS
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.14M | -9.30M | -29.42M | -30.37M | -32.79M |
| Total Depreciation and Amortization | 309.00K | 375.00K | 443.00K | 487.00K | 544.00K |
| Total Amortization of Deferred Charges | -250.00K | -250.00K | -250.00K | 0.00 | 500.00K |
| Total Other Non-Cash Items | 1.65M | 1.95M | 2.32M | 2.06M | 2.99M |
| Change in Net Operating Assets | -18.45M | -13.94M | 3.94M | -1.30M | 4.46M |
| Cash from Operations | -17.89M | -21.17M | -22.96M | -29.13M | -24.30M |
| Capital Expenditure | -49.00K | -49.00K | -61.00K | -82.00K | 10.00K |
| Sale of Property, Plant, and Equipment | 14.00K | 14.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -35.00K | -35.00K | -61.00K | -82.00K | 10.00K |
| Total Debt Issued | 2.50M | 1.75M | 0.00 | 5.00M | 10.00M |
| Total Debt Repaid | -2.84M | -1.80M | -3.29M | -1.80M | -450.00K |
| Issuance of Common Stock | 16.41M | 14.67M | 14.67M | 12.61M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -49.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -749.00K | -853.00K | -784.00K | -1.03M | -800.00K |
| Cash from Financing | 15.32M | 13.77M | 10.60M | 14.78M | 8.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.60M | -7.43M | -12.42M | -14.43M | -15.59M |